Characterisation of human prostate epithelial progenitor differentiation in response to androgens

Annals of the Royal College of Surgeons of England

Volumn 93, Issue 6, 2011, Pages 424-428

  Heer, Rakesh ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Androgen receptor; Prostate cancer; Stem cells

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROGEN RECEPTOR ANTAGONIST; ANILIDE; ANTIANDROGEN; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; BICALUTAMIDE; CYSTEINE PROTEINASE INHIBITOR; DIFFERENTIATION ANTIGEN; LEUPEPTIN; METRIBOLONE; NITRILE; TESTOSTERONE DERIVATIVE; TOLUENESULFONIC ACID DERIVATIVE; TUMOR MARKER;

AGED; ARTICLE; CANCER STEM CELL; CELL TRANSFORMATION; DRUG EFFECT; EPITHELIUM CELL; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANDROGEN RECEPTOR ANTAGONISTS; ANDROGENS; ANILIDES; ANTIGENS, DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE PROTEINASE INHIBITORS; EPITHELIAL CELLS; HUMANS; LEUPEPTINS; MALE; METRIBOLONE; MIDDLE AGED; NEOPLASTIC STEM CELLS; NITRILES; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TESTOSTERONE CONGENERS; TOSYL COMPOUNDS; TUMOR MARKERS, BIOLOGICAL;

EID: 80052569977     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/10.1308/147870811X589245     Document Type: Article

References (27)

1. Prostate cancer statistics. Cancer Research UK. (cited June 2011).
2. Isaacs JT. Prostate stem cells and benign prostatic hyperplasia. Prostate 2008; 68: 1,025-1,034.
3. Lawson DA, Witte ON. Stem cells in prostate cancer initiation and progression. J Clin Invest 2007; 117: 2,044-2,050.
4. Sugimura Y, Cunha GR, Donjacour AA. Morphological and histological study of castration-induced degeneration and androgen-induced regeneration in the mouse prostate. Biol Reprod 1986; 34: 973-983.
5. Collins AT, Habib FK, Maitland NJ, Neal DE. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 2001; 114(Pt 21): 3,865-3,872.
6. Richardson GD, Robson CN, Lang SH et al. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004; 117(Pt 16): 3,539-3,545.
7. Collins AT, Berry PA, Hyde C et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 1,0946-10,951.
8. Miki J, Furusato B, Li H et al. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 2007; 67: 3,153-3,161.
9. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 2007; 67: 6,796-6,805.
10. Bonkhoff H. Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. Eur Urol 1996; 30: 201-205.
11. Maitland NJ, Collins AT. Prostate cancer stem cells: a new target for therapy. J Clin Oncol 2008; 26: 2,862-2,870.
12. Chen CD, Welsbie DS, Tran C et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004; 10: 33-39.
13. Attard G, Cooper CS, de Bono JS. Steroid hormone receptors in prostate cancer: a hard habit to break? Cancer Cell 2009; 16: 458-462.
14. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1: 34-45.
15. Isaacs JT. The biology of hormone refractory prostate cancer. Why does it develop? Urol Clin North Am 1999; 26: 263-273.
16. Hudson DL, O'Hare M, Watt FM, Masters JR. Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab Invest 2000; 80: 1,243-1,250.
17. English HF, Santen RJ, Isaacs JT. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987; 11: 229-242.
18. Sugimura Y, Foster BA, Hom YK et al. Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol 1996; 40: 941-951.
19. Heer R, Collins AT, Robson CN et al. KGF suppresses alpha2beta1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium. J Cell Sci 2006; 119(Pt 7): 1,416-1,424.
20. Robinson EJ, Neal DE, Collins AT. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 1998; 37: 149-160.
21. Heer R, Robson CN, Shenton BK, Leung HY. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population. J Cell Physiol 2007; 212: 572-578.
22. Lin HK, Wang L, Hu YC et al. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 2002; 21: 4,037-4,048.
23. Kemppainen JA, Lane MV, Sar M, Wilson EM. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 1992; 267: 968-974.
24. Cunha GR, Young P. Inability of Tfm (testicular feminization) epithelial cells to express androgen-dependent seminal vesicle secretory proteins in chimeric tissue recombinants. Endocrinology 1991; 128: 3,293-3,298.
25. Krongrad A, Wilson CM, Wilson JD et al. Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol Cell Endocrinol 1991; 76: 79-88.
26. Uzgare AR, Xu Y, Isaacs JT. In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue. J Cell Biochem 2004; 91: 196-205.
27. Scadden DT. The stem-cell niche as an entity of action. Nature 2006; 441: 1,075-1,079.